Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
World
Lizzy Davies

Ghana is first country to approve Oxford malaria vaccine

Two vials of R21/Matrix-M vaccine
The R21/Matrix-M vaccine has shown efficacy levels of 77%. Photograph: Yasuyoshi Chiba/AFP/Getty Images

Ghana has become the first country to approve a highly effective malaria vaccine developed at Oxford university in the UK.

The R21/Matrix-M vaccine, the first to exceed the World Health Organization’s target of 75% efficacy, has been cleared for use by Ghana’s Food and Drugs Authority in children aged 5-36 months, the group at highest risk of death from malaria.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.